Project Details
Description
A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adeno-Associated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults with Hemophilia B
Status | Finished |
---|---|
Effective start/end date | 9/17/12 → 12/31/16 |
Funding
- BAXTER HEALTHCARE CORP
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.